1. Reasons for discontinuation of novel oral anticoagulant therapy in patients with atrial fibrillation

   Mitrovic, D., Folkeringa, R., Veeger, N. & van Roon, E., 17-Feb-2020, In : Current Medical Research and Opinion. p. 1-7 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Early treatment response may predict long-term mepolizumab benefit in severe asthma

   Kroes, J. A., Wiegman, M. I., Van der Meer, A-N., Gijtenbeek, R. G. P., De Jong, K., Zielhuis, S. W., Van Roon, E. N. & Ten Brinke, A., 28-Sep-2019, In : European Respiratory Journal. 54, Suppl. 63, 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. No decrease in fracture risk despite 15 years of treatment evolution in multiple myeloma patients: A Danish nationwide case-control study

   Oortgiesen, B., Driessen, A., Hoogendoorn, M., Kibbelaar, R., Veeger, N., Van Der Bergh, J., Vestergaard, P., De Vries, F. & Van Roon, E., 13-Nov-2019, In : Blood. 134, Suppl.1

   Research output: Contribution to journal › Article › Academic › peer-review

4. Role of disease modifying treatment in the risk of alloimmunization in transfused patients with myelodysplastic syndromes: A population-based study

   Rozema, H., Kibbelaar, R., Veeger, N., Hoogendoorn, M. & Van Roon, E., 13-Nov-2019, In : Blood. 134, Suppl. 1

   Research output: Contribution to journal › Article › Academic › peer-review

5. Peripheral neuropathy and hypovitaminosis d are associated in multiple myeloma patients

   Oortgiesen, B., Kroes, H., Scholtens, P., Hoogland, J., Dannenberg-De Keijzer, P., Siemes, C., Jansman, F., Kibbelaar, R., Veeger, N., Hoogendoorn, M. & Van Roon, E., 1-Nov-2019, In : Blood. 134, Suppl. 1

   Research output: Contribution to journal › Article › Academic › peer-review

View all (247) »